StonvexLoading…
StonvexStonvexStonvexCore line items from RSG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.59B | $16.03B | $14.96B | $13.51B |
Operating Income | $3.30B | $3.20B | $2.78B | $2.39B |
Net Income | $2.14B | $2.04B | $1.73B | $1.49B |
EPS (Diluted) | $6.85 | $6.49 | $5.47 | $4.69 |
Total Assets | $34.37B | $32.40B | $31.41B | $29.05B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $76.00M | $74.00M | $140.00M | $143.00M |
Free Cash Flow OCF − CapEx | $2.41B | $2.08B | $1.99B | $1.74B |
Shares Outstanding | 312.17M | 314.81M | 316.67M | 317.08M |